Anuh Pharma Share Price

Anuh Pharma

CMP as on22-Oct-21 15:29

₹ 107.80
-2.4 -2.18%

Open

₹ 112.80

Turnover (lac)

₹ 125

Prev. Close

₹ 110.20

Day's Vol (shares)

₹ 50,910

Day's Range

₹ 105.50
₹ 112.80

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 26-Jul-2021 - -
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2021 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 6th August, 2021, inter alia: 1)To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June, 2021; and 2)To consider any other matter with the permission of the Chairman. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Companys Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from Wednesday, 30th June, 2021 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2021 i.e. upto Sunday, 8th August, 2021 (both days inclusive). Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Outcome of the Board Meeting held on 06.08.2021. (As Per BSE Announcement dated on 06.08.2021)
Board Meeting - 10-May-2021 - -
Anuh Pharma Ltd has informed BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on May 21, 2021, inter alia::1. To consider and approve Audited Financial Results of the Company for the quarter & year ended March 31, 2021; and2. To consider and recommend final Dividend, if any, for the financial year 2020-21.Further, pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Companys Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from March 31, 2021 till 48 hours after the declaration of Audited Financial Results of the Company for the quarter & year ended March 31, 2021 i.e. upto May 23, 2021 (both days inclusive). Anuh Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2021, inter alia, has recommended final dividend of Rs. 1.50/- per equity shares of face value of Rs. 5/- each (i.e. 30%) for the financial year ended March 31, 2021, subject to the approval of the Shareholders at the ensuing 61st Annual General Meeting of the Company. Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Outcome of Board Meeting held today i.e. Friday, 21st May, 2021. (As Per BSE Announcement Dated on 21.05.2021)
Board Meeting - 29-Jan-2021 - -
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (LODR) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 9th February, 2021, inter alia: 1) To consider and approve Unaudited Financial Results of the Company for the quarter & nine months ended 31st December, 2020; 2) To consider any other matter with the permission of the Chairman. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Companys Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from Thursday, 31st December, 2020 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter & nine months ended December 31, 2020 i.e. upto Thursday, 11th February, 2021 (both days inclusive). Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Tuesday, 9th February, 2021, inter-alia considered and approved the following agenda Items: 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter & nine months ended December 31, 2020; and 2. Appointment of Mr. Jitendra Shah as Chief Operating Officer and designated him as a Key Managerial Personnel of the Company w.e.f. March 01, 2021. (AS Per BSE Announcement Dated on 09.02.2021)
Board Meeting - 08-Jan-2021 - -
Please note at the Board Meeting held on 08/01/2021, the following items were considered and approved :1)1. Appointment of Mr. Bipin N. Shah as a Non-Executive Director and Vice Chairman of the Company with effect from 08th January, 2021 2) The relinquishment of position of Managing Director by Mr. Bipin N. Shah for the purpose of Board Restructuring 3) The appointment and re-designation of Mr. Ritesh B. Shah and Mr. Vivek B. Shah as Joint Managing Directors from the position of Whole Time Directors & Chief Executive Officers w.e.f. 8th January, 2021
Board Meeting - 26-Oct-2020 - -
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2020 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (LODR) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 6th November, 2020, inter alia: 1) To consider and approve Unaudited Financial Results of the Company for the quarter & half year ended 30th September, 2020; 2)To consider any other matter with the permission of the Chairman. Further, pursuant to the Securities and Exchange Board of India (PIT) Regulations, 2015 and in compliance with the Companys Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from Thursday, 1st October, 2020 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter & half year ended September 30, 2020 i.e. upto Sunday, 8th November, 2020 (both days inclusive). Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Friday, 6th November, 2020, inter-alia considered and approved the following agenda Items: 1.The Un-audited Financial Results along with Limited Review Report thereon for the Quarter & Half year ended September 30, 2020; and 2.The proposal for listing of Equity Shares of the Company on National Stock Exchange of India Limited (NSE) subject to meeting of the criteria of NSE Listing. (As per BSE Announcement Dated on 06/11/2020) The Board of Directors of the Company at its meeting held today have inter-alia considered and approved the Unaudited Financial Results for the quarter and half year ended 30.09.2020. Please note that the results are appended, with the Statement of Assets & Liabilities, Cash Flow Statement and Report of Statutory Auditors. Kindly take this on your records. (AS Per BSE Announcement Dated on 07.11.2020)
Open ZERO Brokerage Demat Account